Scinai Immunotherapeutics (SCNI) Total Non-Current Liabilities (2024 - 2025)
Scinai Immunotherapeutics (SCNI) has disclosed Total Non-Current Liabilities for 2 consecutive years, with $1.9 million as the latest value for Q4 2025.
- Quarterly Total Non-Current Liabilities rose 16.4% to $1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, up 16.4% year-over-year, with the annual reading at $1.9 million for FY2025, 16.4% up from the prior year.
- Total Non-Current Liabilities hit $1.9 million in Q4 2025 for Scinai Immunotherapeutics, up from $1.7 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $1.9 million in Q4 2025 to a low of $1.7 million in Q4 2024.